First-Line Antibiotic Treatments for Cellulitis
For typical cases of cellulitis without systemic signs of infection, first-line treatment should be an antibiotic active against streptococci, such as penicillin, amoxicillin, amoxicillin-clavulanate, dicloxacillin, cephalexin, or clindamycin for a 5-day course. 1
Antibiotic Selection Based on Presentation
Uncomplicated Cellulitis (Mild, Non-Purulent)
- Oral antibiotics active against streptococci are recommended as first-line therapy 1
- Preferred options include:
- Duration of therapy should be 5 days, with extension if infection has not improved within this period 1, 2
Cellulitis with Systemic Signs (Moderate Non-Purulent)
- Systemic antibiotics are indicated 1
- Many clinicians include coverage against methicillin-susceptible S. aureus (MSSA) 1
- Options include the same antibiotics as for uncomplicated cellulitis, but may require initial IV administration depending on severity 1
Special Circumstances Requiring MRSA Coverage
- MRSA coverage should be considered in cellulitis associated with: 1
- Penetrating trauma
- Evidence of MRSA infection elsewhere
- Nasal colonization with MRSA
- Injection drug use
- Systemic inflammatory response syndrome (SIRS)
- Options for MRSA coverage include: 1
- Intravenous: vancomycin, daptomycin, linezolid, or telavancin
- Oral: doxycycline, clindamycin, or trimethoprim-sulfamethoxazole (SMX-TMP)
Severely Compromised Patients
- Broad-spectrum antimicrobial coverage may be considered 1
- Recommended empiric regimen: vancomycin plus either piperacillin-tazobactam or imipenem/meropenem 1
Duration of Treatment
- 5-day course is recommended for uncomplicated cellulitis 1, 2
- Treatment should be extended if the infection has not improved within 5 days 1, 2
- Recent studies show that 5-6 days of therapy is as effective as longer courses (10-12 days) if clinical improvement occurs 1, 2, 3
Important Considerations
Microbiology
- Most cases of cellulitis are caused by β-hemolytic Streptococcus and Staphylococcus aureus 4, 5
- MRSA is an unusual cause of typical cellulitis, with studies showing successful treatment with β-lactams in 96% of patients 1
- In areas with high MRSA prevalence, treatment success rates may be higher with trimethoprim-sulfamethoxazole or clindamycin compared to cephalexin 6
Adjunctive Measures
- Elevation of the affected area is recommended to hasten improvement 1
- Treatment of predisposing factors (edema, obesity, eczema, venous insufficiency, toe web abnormalities) is important 1
- For lower-extremity cellulitis, careful examination of interdigital toe spaces is recommended 1
- Systemic corticosteroids (e.g., prednisone 40 mg daily for 7 days) could be considered in non-diabetic adult patients 1
Outpatient vs. Inpatient Treatment
- Outpatient therapy is recommended for patients who do not have SIRS, altered mental status, or hemodynamic instability 1
- Hospitalization should be considered for: 1
- Concern for deeper or necrotizing infection
- Poor adherence to therapy
- Severely immunocompromised patients
- Failing outpatient treatment
Common Pitfalls
- Treating for MRSA when not indicated - MRSA is an unusual cause of typical cellulitis 1, 5
- Using combination therapy (SMX-TMP plus cephalexin) for pure cellulitis - studies show this is no more effective than cephalexin alone 1
- Extending treatment unnecessarily - 5 days is sufficient for uncomplicated cellulitis if clinical improvement occurs 1, 2
- Failing to address predisposing factors, which can lead to recurrence 1
- Missing clinical mimickers of cellulitis such as venous stasis dermatitis, contact dermatitis, eczema, and lymphedema 5